Adults as young as 50 may now qualify for an RSV vaccine if they have certain health conditions, according to a quiet update ...

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...

Among hospitalized veterans, a prior RSV or flu infection more than doubles the odds of a secondary pneumococcal infection, whereas prior SARS-CoV-2 infection is linked to a reduced risk.

U.S. vaccine advisers will discuss recommendations for flu vaccines containing the preservative thimerosal and a combination measles shot for children this month, putting topics of concern to ...

CINCINNATI (WKRC) — A new sub-variant of COVID-19, known as "Nimbus," is spreading rapidly across the United States, presenting with atypical symptoms that differ from those commonly associated ...

Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu shots in pared-down meeting Public will get its first look at how RFK Jr.’s new panel will weigh evidence on vaccines ...

by: Justin Dennis Posted: Jun 13, 2025 / 03:57 PM EDT Updated: Jun 13, 2025 / 11:17 PM EDT [Watch in the player above: How to know whether you have COVID, flu, RSB or strep] ...

The company intends to have mRESVIA available for both younger adults at increased risk (ages 18-59) and older adults (ages 60+) in the U.S. for the 2025-2026 respiratory virus season. The company ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness. The drug, ...

Key takeaways: The FDA approved the monoclonal antibody clesrovimab-cfor for preventing RSV disease in babies. Unlike nirsevimab, which has weight-based dosing, clesrovimab has a fixed dose.